Follow Us:
Teresa Purzner, MD

For the 2014-15 academic year, Teresa Purzner, MD was named the NREF/Medtronic Research Fellow for her project titled “Combining Mass Spectrometry and Development Genetics for Develop Targeted Brain Tumor Therapy.”

She has successfully parlayed that experience into significant funding from other sources, including the American Academy of Neurological Surgery “Academy Award.”

During the 2017 Academy meeting in Santa Barbara, California, NREF Director, William T. Couldwell, MD, PhD, FAANS, had an opportunity to speak with Dr. Purzner about the impact of NREF funding, her plans for the future and being a two-neurosurgeon household.

Dr. Couldwell: Can you describe how the NREF funding helped you acquire significant other funding?

Dr. Purzner: When I received NREF funding, I had very preliminary data. It is hard to get funding from other resources with preliminary data. I really needed proof of concept, proof that the hypothesis was likely true. What the NREF funding did was give me a year of cushion time, where I could do the experiments that could prove the hypothesis with high potential.

Because I was able to do this, the very next year I was awarded a 200 thousand dollar fellowship from another source that funded me for 3 years, as well as providing the opportunity to achieve some preclinical data. Once we had the preclinical data showing some efficacy in the animals, we were able to acquire other grants to pursue the work further, ultimately about 500 thousand dollars.

Dr. C: Did the Canadian government help you with funding as well?

Dr. P: Unfortunately, no. Because I was a Canadian resident working in the US, I was unable to qualify for Canadian funding and many NIH resources. It narrowed the scope to foundation funding, private and philanthropic sources. To receive funding from these sources, we really needed good preclinical data to demonstrate clinical translational potential. That is why the NREF funding was such a blessing to get, to allow me to get preliminary data as a necessary first step that enabled other funding.

Dr. C: Awesome. What are your goals?

Dr. P: I love developmental biology, and its relevance to understanding cancer with rational and targeted therapies. My goal is to continue to study developmental biology, apply my knowledge and interest in drug development, and use my skills and interest in clinical trials to apply to clinical treatment. I would like to pursue high yield targeted therapies.


Dr. C: Where do you plan on working following your training?

Dr. P: My husband and I have 2 more years of clinical training left in residency after we finish our PhDs; we will have to see who is willing to hire 2 married neurosurgeons at the same time!






Click here for a brief summary of Dr. Purzner’s research.

| | |